Cargando…
Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization study
BACKGROUND: C-type natriuretic peptide (CNP) is a known target for promoting growth and has been implicated as a therapeutic opportunity for the prevention and treatment of cardiovascular disease (CVD). This study aimed to explore the effect of CNP on CVD risk using the Mendelian randomization (MR)...
Autores principales: | Cronjé, Héléne T., Karhunen, Ville, Hovingh, G. Kees, Coppieters, Ken, Lagerstedt, Jens O., Nyberg, Michael, Gill, Dipender |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134514/ https://www.ncbi.nlm.nih.gov/pubmed/37101178 http://dx.doi.org/10.1186/s12916-023-02867-x |
Ejemplares similares
-
Inhibition of interleukin 6 signalling and renal function: A Mendelian randomization study
por: Ryan, David K., et al.
Publicado: (2021) -
Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease: Evidence From Mendelian Randomization
por: Cupido, Arjen J., et al.
Publicado: (2022) -
Modifiable Risk Factors for Intracranial Aneurysm and Aneurysmal Subarachnoid Hemorrhage: A Mendelian Randomization Study
por: Karhunen, Ville, et al.
Publicado: (2021) -
Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization
por: Woolf, Benjamin, et al.
Publicado: (2023) -
Genetically Predicted Midlife Blood Pressure and Coronary Artery Disease Risk: Mendelian Randomization Analysis
por: Gill, Dipender, et al.
Publicado: (2020)